Multiple myeloma. Analysis of fifty cases. 1989

P Venugopal, and A Rajni, and R Gopal, and C N Nair, and P A Kurkure, and T K Saikia, and K S Nadkarni, and S K Pai, and V R Pai, and S H Advani

Fifty patients of multiple myeloma have been studied. Seventy eight per cent of the patients were in the 5th, 6th and 7th decades of life. Commonest presenting feature was bone pains (76%). 8%, 20% belonged to stage I, II and III respectively. Skull (58%), ribs (52%) and pelvis (24%) were most commonly involved. Immunoelectrophoresis revealed IgG type of myeloma in 76% and IgA type in 10% cases. Bence-Jones proteinuria was seen in 60% of patients; Kappa specificity was commoner than lambda. Overall survival at 30 months was 50%. The survival was adversely influenced by advanced stage, higher plasma cell count in the bone marrow, low haemoglobin and high serum creatinine values.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

P Venugopal, and A Rajni, and R Gopal, and C N Nair, and P A Kurkure, and T K Saikia, and K S Nadkarni, and S K Pai, and V R Pai, and S H Advani
February 1964, The Ohio State medical journal,
P Venugopal, and A Rajni, and R Gopal, and C N Nair, and P A Kurkure, and T K Saikia, and K S Nadkarni, and S K Pai, and V R Pai, and S H Advani
January 1964, Journal of the Indian Medical Association,
P Venugopal, and A Rajni, and R Gopal, and C N Nair, and P A Kurkure, and T K Saikia, and K S Nadkarni, and S K Pai, and V R Pai, and S H Advani
January 1965, Polski tygodnik lekarski (Warsaw, Poland : 1960),
P Venugopal, and A Rajni, and R Gopal, and C N Nair, and P A Kurkure, and T K Saikia, and K S Nadkarni, and S K Pai, and V R Pai, and S H Advani
April 1967, Wiadomosci lekarskie (Warsaw, Poland : 1960),
P Venugopal, and A Rajni, and R Gopal, and C N Nair, and P A Kurkure, and T K Saikia, and K S Nadkarni, and S K Pai, and V R Pai, and S H Advani
November 1984, Zhonghua nei ke za zhi,
P Venugopal, and A Rajni, and R Gopal, and C N Nair, and P A Kurkure, and T K Saikia, and K S Nadkarni, and S K Pai, and V R Pai, and S H Advani
December 2009, Zhongguo shi yan xue ye xue za zhi,
P Venugopal, and A Rajni, and R Gopal, and C N Nair, and P A Kurkure, and T K Saikia, and K S Nadkarni, and S K Pai, and V R Pai, and S H Advani
January 1991, Zhonghua zhong liu za zhi [Chinese journal of oncology],
P Venugopal, and A Rajni, and R Gopal, and C N Nair, and P A Kurkure, and T K Saikia, and K S Nadkarni, and S K Pai, and V R Pai, and S H Advani
June 1950, The American journal of roentgenology and radium therapy,
P Venugopal, and A Rajni, and R Gopal, and C N Nair, and P A Kurkure, and T K Saikia, and K S Nadkarni, and S K Pai, and V R Pai, and S H Advani
July 1992, Ethiopian medical journal,
P Venugopal, and A Rajni, and R Gopal, and C N Nair, and P A Kurkure, and T K Saikia, and K S Nadkarni, and S K Pai, and V R Pai, and S H Advani
February 1959, A.M.A. archives of internal medicine,
Copied contents to your clipboard!